Preoperative Neurological Changes on Outcomes in Large-Vessel Occlusion Due to Intracranial Atherosclerotic Disease

Takeshi Yoshimoto1,2, Kanta Tanaka3,4, Junpei Koge4,5

  • 1Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital, Tsukuba, Japan.

Neurosurgery Practice
|October 30, 2025
PubMed

Insights

Neurological deterioration before endovascular therapy (EVT) in intracranial atherosclerotic disease with large-vessel occlusion (ICAD-LVO) is linked to poorer outcomes. Early detection and intervention are crucial for improving results in these stroke patients.

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Vascular Neurology

Background:

  • Intracranial atherosclerotic disease with large-vessel occlusion (ICAD-LVO) is a significant cause of ischemic stroke.
  • Endovascular therapy (EVT) is a critical treatment for acute ischemic stroke caused by LVO.
  • Predicting outcomes in ICAD-LVO patients undergoing EVT remains a challenge.

Purpose of the Study:

  • To investigate the association between neurological deterioration prior to EVT and patient outcomes.
  • To analyze outcomes in ICAD-LVO patients stratified by neurological severity changes.
  • To identify factors influencing treatment success in EVT for ICAD-LVO.

Main Methods:

  • A Japanese multicenter registry study included 480 patients with acute ICAD-LVO undergoing EVT (2017-2019).
  • Patients were categorized based on National Institutes of Health Stroke Scale (NIHSS) score changes: mild symptoms, symptom deterioration, and severe symptoms.
  • Outcomes assessed included favorable modified Rankin Scale (mRS) scores at 90 days, ordinal mRS shift, and symptomatic intracranial hemorrhage, analyzed using multivariable logistic regression.

Main Results:

  • Patients experiencing symptom deterioration (38.2%) and severe symptoms (35.3%) had significantly lower favorable outcomes compared to those with mild symptoms (62.9%).
  • Neurological deterioration pre-EVT was associated with poorer functional outcomes (adjusted odds ratio 0.30 for deterioration, 0.47 for severe symptoms).
  • Symptomatic intracranial hemorrhage rates were similar across groups (0% for mild and deterioration, 1.9% for severe symptoms).

Conclusions:

  • Worsening neurological symptoms before EVT in ICAD-LVO patients correlate with reduced chances of a favorable outcome.
  • Prompt identification of neurological deterioration and timely EVT intervention are essential for improving patient outcomes.
  • This study highlights the importance of monitoring neurological status during acute stroke management for ICAD-LVO.
Abstract